News Snapshot:
Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so. Indonesia’s food and drugs agency greenlighted the use of Walvax Biotechnology’s mRNA vaccine, which has been in development for more than two years and targets the original strain of the coronavirus. However, Walvax has yet to publish efficacy readings for its vaccine, now known as AWcorna, from its large late-stage trial which would show how well it can reduce the risk of COVID cases and deaths from the disease. China has...
